Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignancies with few effective therapeutic options.

Biotechnology

Health Care

Therapeutics

Verismo Therapeutics

Bryan Kim

Andrea Campanile

Raymond Luke

Pavel Aprelev

Jacqueline Stief

Laura A Johnson

The Leadership Team at Verismo Therapeutics strategizes and guides the company’s vision in developing innovative CAR technologies for cancer treatment. They oversee clinical development, foster scientific advancements, and ensure operational efficiency, while collaborating closely with advisory board members to drive research and secure funding for groundbreaking therapies.

Leadership Team

Research and Development

Quality and Compliance Team

Leadership Team

About

Team members

Other teams at Verismo Therapeutics

Research and Development

Quality and Compliance Team